Rye bread consumption in early life and reduced risk of advanced prostate cancer

Cancer Causes and Control

Volumn 23, Issue 6, 2012, Pages 941-950

  Torfadottir, Johanna E ^a   Valdimarsdottir, Unnur A ^a,b   Mucci, Lorelei ^b,c   Stampfer, Meir ^b,c   Kasperzyk, Julie L ^b,c   Fall, Katja ^a,d   Tryggvadottir, Laufey ^a,e   Aspelund, Thor ^a,f   Olafsson, Orn ^a   Harris, Tamara B ^g   Jonsson, Eirikur ^h   Tulinius, Hrafn ^a,e   Adami, Hans Olov ^b,i   Gudnason, Vilmundur ^a,f   Steingrimsdottir, Laufey ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^e ICELANDIC CANCER REGISTRY   (Iceland)

^f ICELANDIC HEART ASSOCIATION   (Iceland)

^g NATIONAL INSTITUTE ON AGING   (United States)

^h LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adolescent; AGES Reykjavik study; Diet; Epidemiology; Prostatic neoplasms; Rye bread; Whole grain

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAD; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FISH; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAT; MILK; OAT; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; RYE BREAD;

ADOLESCENT; ADULT; AGED; BREAD; COHORT STUDIES; FOLLOW-UP STUDIES; FOOD HABITS; HUMANS; ICELAND; MALE; MIDDLE AGED; ODDS RATIO; PROSTATIC NEOPLASMS; RISK; RISK REDUCTION BEHAVIOR; SECALE CEREALE; YOUNG ADULT;

EID: 84862499459     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9965-2     Document Type: Article

References (50)

1. World Cancer Research Fund/American Institute for Cancer Research (2007) Food nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC
2. Rastogi T, Devesa S, Mangtani P, Mathew A, Cooper N, Kao R, Sinha R (2008) Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int J Epidemiol 37(1):147-160. doi:10.1093/ije/ dym219 (Pubitemid 351228623)
3. Slavin JL (2000) Mechanisms for the impact of whole grain foods on cancer risk. J Am Coll Nutr 19(3 suppl):300S-307S
4. Adlercreutz H (2007) Lignans and human health. Crit Rev Clin Lab Sci 44(5-6):483-525. doi:10.1080/10408360701612942
5. Tsubaki J, Hwa V, Twigg SM, Rosenfeld RG (2002) Differential activation of the IGF binding protein-3 promoter by butyrate in prostate cancer cells. Endocrinology 143(5):1778-1788 (Pubitemid 34415893)
6. Laaksonen DE, Toppinen LK, Juntunen KS, Autio K, Liukkonen KH, Poutanen KS, Niskanen L, Mykkanen HM (2005) Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome. Am J Clin Nutr 82(6):1218-1227 (Pubitemid 43779720)
7. Leinonen K, Liukkonen K, Poutanen K, Uusitupa M, Mykkanen H (1999) Rye bread decreases postprandial insulin response but does not alter glucose response in healthy Finnish subjects. Euro J Clin Nutr 53(4):262-267 (Pubitemid 29164256)
8. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159(12):1160-1167. doi: 10.1093/aje/kwh161159/12/1160 (Pubitemid 38747263)
9. Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132(6):2208-2225. doi:10.1053/j.gastro.2007.03.050 (Pubitemid 46693749)
10. Hsu IR, Kim SP, Kabir M, Bergman RN (2007) Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr 86(3): s867-s871
11. Lewis JE, Soler-Vila H, Clark PE, Kresty LA, Allen GO, Hu JJ (2009) Intake of plant foods and associated nutrients in prostate cancer risk. Nutr Cancer 61(2):216-224. doi:10.1080/01635580802419756
12. Jain MG, Hislop GT, Howe GR, Ghadirian P (1999) Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. Nutr Cancer 34(2):173-184. doi:10.1207/S15327914NC3402-8 (Pubitemid 29511115)
13. La Vecchia C, Chatenoud L, Negri E, Franceschi S (2003) Session: whole cereal grains, fibre and human cancer wholegrain cereals and cancer in Italy. Proc Nutr Soc 62(1):45-49. doi:10.1079/PNS2002235 (Pubitemid 36569806)
14. Chatenoud L, Tavani A, La Vecchia C, Jacobs DR Jr, Negri E, Levi F, Franceschi S (1998) Whole grain food intake and cancer risk. Int J Cancer 77(1):24-28 (Pubitemid 28308547)
15. Nimptsch K, Kenfield S, Jensen MK, Stampfer MJ, Franz M, Sampson L, Brand-Miller JC, Willett WC, Giovannucci E (2011) Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer. Cancer Causes Control 22(1):51-61. doi:10.1007/s10552-010- 9671-x
16. Egeberg R, Olsen A, Christensen J, Johnsen NF, Loft S, Overvad K, Tjonneland A (2011) Intake of whole-grain products and risk of prostate cancer among men in the Danish diet, cancer and health cohort study. Cancer Causes Control 22(8):1133-1139. doi:10.1007/s10552-011-9789-5
17. Adlercreutz H, Mazur W (1997) Phyto-oestrogens and Western diseases. Ann Med 29(2):95-120 (Pubitemid 27226319)
18. Bylund A, Zhang JX, Bergh A, Damber JE, Widmark A, Johansson A, Adlercreutz H, Aman P, Shepherd MJ, Hallmans G (2000) Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate 42(4):304-314. doi:10.1002/(SICI)1097-0045(20000301)42: 4〈304:AID-PROS8〉3.0.CO;2-Z (Pubitemid 30104574)
19. Landstrom M, Zhang JX, Hallmans G, Aman P, Bergh A, Damber JE, Mazur W, Wahala K, Adlercreutz H (1998) Inhibitory effects of soy and rye diets on the development of dunning R3327 prostate adenocarcinoma in rats. Prostate 36(3):151-161. doi:10.1002/(SICI)1097-0045(19980801)36:3〈151:AID- PROS2〉3.0.CO;2-K (Pubitemid 28341126)
20. Landberg R, Andersson SO, Zhang JX, Johansson JE, Stenman UH, Adlercreutz H, Kamal-Eldin A, Aman P, Hallmans G (2010) Rye whole grain and bran intake compared with refined wheat decreases urinary C-peptide, plasma insulin, and prostate specific antigen in men with prostate cancer. J Nutr 140(12):2180-2186. doi:10.3945/jn.110.127688
21. Bylund A, Lundin E, Zhang JX, Nordin A, Kaaks R, Stenman UH, Aman P, Adlercreutz H, Nilsson TK, Hallmans G, Bergh A, Stattin P (2003) Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer. Euro J Cancer Prev 12(5):407-415. doi:10.1097/01.cej.0000090180.08740.05 (Pubitemid 37338815)
22. Torfadottir JE, Steingrimsdottir L, Mucci L, Aspelund T, Kasperzyk JL, Olafsson O, Fall K, Tryggvadottir L, Harris TB, Launer L, Jonsson E, Tulinius H, Stampfer M, Adami HO, Gudnason V, Valdimarsdottir UA (2012) Milk intake in early life and risk of advanced prostate cancer. Am J Epidemiol 175(2): 144-153. doi:10.1093/aje/kwr289
23. Jónsson G (1998) Changes in food consumption in Iceland, 1770-1940. Scand Econ Hist Rev XLVI 1:24-41
24. Sigurjonsson J (1943) Survey on diet and health in Iceland (1939-1940). Icelandic Nutrition Council, Reykjavik
25. Harris TB, Launer LJ, Eiriksdottir G, Kjartansson O, Jonsson PV, Sigurdsson G, Thorgeirsson G, Aspelund T, Garcia ME, Cotch MF, Hoffman HJ, Gudnason V (2007) Age, gene/environment susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol 165(9):1076-1087. doi:10.1093/aje/kwk115 (Pubitemid 46598837)
26. Eysteinsdottir T, Gunnarsdottir I, Thorsdottir I, Harris T, Launer LJ, Gudnason V, Steingrimsdottir L (2011) Validity of retrospective diet history: assessing recall of midlife diet using food frequency questionnaire in later life. J Nutr Health Aging 15(10): 809-814
27. Eysteinsdottir T, Gunnarsdottir I, Thorsdottir I, Harris T, Launer LJ, Gudnason V, Steingrimsdottir L (2010) Validity of retrospective diet history: assessing recall of midlife diet using food frequency questionnaire in later life. JNHA (in press)
28. Vilbergsson S, Sigurdsson G, Sigvaldason H, Hreidarsson AB, Sigfusson N (1997) Prevalence and incidence of NIDDM in Iceland: evidence for stable incidence among males and females 1967-1991-the Reykjavik Study. Diabet Med 14(6):491-498. doi:10.1002/(SICI)1096-9136(199706)14:6〈491:AID- DIA365〉3.0.CO;2-1 (Pubitemid 27286523)
29. Møller B, Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, Talback M, Haldorsen T (2002) Prediction of cancer incidence in the Nordic countries up to the year 2020. Euro J Cancer Prev 11(Suppl 1):S1-S96 (Pubitemid 34759915)
30. Jonasson JG, Tryggvadottir L (2007) Iceland. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (eds) Cancer incidence in five continents. International agency for research on cancer (IARC Scientific Publications No. 160). Lyon, p 312
31. Icelandic Cancer Registry Homepage of the Icelandic Cancer Registry (2006) http://www.cancerregistry.is. Accessed July 2010
32. Bray F, Klint A, Gislum M, Hakulinen T, Engholm G, Tryggvadottir L, Storm HH (2010) Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncol 49(5):644-654
33. Andresdottir MB, Sigfusson N, Sigvaldason H, Gudnason V (2003) Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik Study. Am J Epidemiol 158(9):844-851 (Pubitemid 37323246)
34. Chen PC, Tseng TC, Hsieh JY, Lin HW (2011) Association between stroke and patients with pelvic inflammatory disease: a nationwide population-based study in Taiwan. Stroke J Cerebr Circul 42(7):2074-2076. doi:10.1161/STROKEAHA.110. 612655
35. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM (1991) Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63(6):963-966
36. Hemminki K, Li X (2002) Cancer risks in second-generation immigrants to Sweden. Int J Cancer 99(2):229-237. doi:10.1002/ijc.10323 (Pubitemid 34309480)
37. Dwyer JT, Coleman KA (1997) Insights into dietary recall from a longitudinal study: accuracy over four decades. Am J Clin Nutr 65(4 suppl):1153S-1158S (Pubitemid 27152578)
38. Strom SS, Yamamura Y, Duphorne CM, Spitz MR, Babaian RJ, Pillow PC, Hursting SD (1999) Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer 33(1):20-25. doi:10.1080/ 01635589909514743 (Pubitemid 29196118)
39. McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, Freudenheim JL, Wilkinson GS, Graham S (2005) Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 53(1):33-41. doi: 10.1207/s15327914nc5301-4 (Pubitemid 43068551)
40. Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO, Heinonen SM, Adlercreutz H, Adami HO, Gronberg H, Balter KA (2006) Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 17(2):169-180. doi:10.1007/s10552-005-0342-2 (Pubitemid 43121766)
41. Stattin P, Bylund A, Biessy C, Kaaks R, Hallmans G, Adlercreutz H (2004) Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control 15(10):1095-1102 (Pubitemid 41449287)
42. Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M (2002) Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int J Cancer 99(1):124-129. doi:10.1002/ijc.10313 (Pubitemid 34273209)
43. Kilkkinen A, Virtamo J, Virtanen MJ, Adlercreutz H, Albanes D, Pietinen P (2003) Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study. Cancer Epidemiol Biomarkers Prev 12(11 Pt 1):1209-1212 (Pubitemid 37499446)
44. Pettersson K, Gustafsson JA (2001) Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 63:165-192. doi: 10.1146/annurev.physiol.63.1. 16563/1/165 (Pubitemid 32318327)
45. Hall JM, Couse JF, Korach KS (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276(40):36869-36872. doi:10.1074/jbc.R100029200R100029200
46. Mueller SO, Simon S, Chae K, Metzler M, Korach KS (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80(1):14-25. doi:10.1093/toxsci/kfh147kfh147 (Pubitemid 38967392)
47. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28(10):1221-1227 (Pubitemid 17156038)
48. Arts CJ, Govers CA, van den Berg H, Wolters MG, van Leeuwen P, Thijssen JH (1991) In vitro binding of estrogens by dietary fiber and the in vivo apparent digestibility tested in pigs. J Steroid Biochem Mol Biol 38(5):621-628
49. Collier A, Ghosh S, McGlynn B, Hollins G (2011) Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: a review. Am J Clin Oncol. doi:10.1097/COC. 0b013e318201a406
50. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363(9418):1346-1353. doi:10.1016/S0140-6736(04)16044-3S0140-6736(04)16044-3 (Pubitemid 38529873)